Clinical trial

Levosimendan In Ambulatory Heart Failure Patients

NCT04705337

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-12-15

PhasePHASE4

Study timeline

Study start (actual)2021-12-15Date precision: day

Registry last updated2025-05-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure New York Heart Association Class IIIunresolved

Heart Failure New York Heart Association Class IVunresolved

Heart Failure, Systolicunresolved

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

LevosimendanDRUG

Sponsors & collaborators

Medical University of Bialystoklead sponsor

Medical Research Agency, Polandcollaborator

University of Opolecollaborator

Medical University of Lodzcollaborator

Poznan University of Medical Sciencescollaborator

Nicolaus Copernicus Universitycollaborator

National Institute of Cardiology, Warsaw, Polandcollaborator

Azienda Ospedaliera dei Collicollaborator

John Paul II Hospital, Krakowcollaborator

Mapped research locations

WarsawPoland2 KrakowPoland2 BydgoszczPoland2 PoznanPoland1 LodzPoland1 WroclawPoland1 BialystokPoland1 GdanskPoland1 KatowicePoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04705337 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.